Hereditary Breast and Ovarian Cancer Syndrome

This is an inherited condition that increases the risk of getting breast and ovarian cancer. It's often caused by changes in the BRCA1 or BRCA2 genes. People with this syndrome need regular screening tests.

Condition

What people with Hereditary Breast and Ovarian Cancer Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Prophylactic Mastectomy for Hereditary Breast and Ovarian Cancer Syndrome?

NameHow it went

About Hereditary Breast and Ovarian Cancer Syndrome

What It Is

Hereditary breast and ovarian cancer (HBOC) syndrome is an inherited condition that greatly raises a person's chance of developing certain cancers, most notably breast cancer and ovarian cancer. It is usually caused by a harmful change, also called a variant or mutation, in one of two genes: BRCA1 or BRCA2. These genes normally help cells repair damaged DNA. When one copy does not work, cells are more likely to build up the kind of damage that can lead to cancer. HBOC is not cancer itself. It is a raised risk that a person carries from birth. More than 60% of women with a harmful BRCA1 or BRCA2 variant develop breast cancer during their lifetime, compared with about 13% of women overall. Ovarian cancer, which here includes cancers that start in the fallopian tubes or the lining of the abdomen, affects roughly 39% to 58% of women with a BRCA1 variant and 13% to 29% with a BRCA2 variant, compared with about 1% of women overall. Men are affected too: BRCA2 in particular raises the risk of prostate cancer and male breast cancer, and both genes modestly raise the risk of pancreatic cancer. Cancers linked to HBOC also tend to appear at younger ages. Even so, some people who carry a harmful variant never develop cancer.

Causes & Risk Factors

HBOC is caused by a harmful BRCA1 or BRCA2 variant inherited from a parent. Everyone has two copies of each gene, one from each parent. Having one working copy is usually enough to protect a cell, but over a lifetime that remaining copy can be damaged in a particular cell, and that cell then loses its ability to repair DNA properly. This is why risk is raised but cancer is not certain, and why other genetic, hormonal and lifestyle factors still play a part. The variant can come from either the mother's or the father's side of the family, and men and women are equally likely to carry and pass it on. Each child of a carrier has a 50% chance of inheriting it. Because not every carrier develops cancer, the variant can pass through generations without an obvious pattern, especially through men. Harmful BRCA variants are found in about 1 in 400 people overall, but they are more common in some groups because of shared ancestry. About 2% of people of Ashkenazi Jewish descent carry one.

How It's Diagnosed

HBOC is diagnosed with a genetic test, usually on a blood or saliva sample, that looks for a harmful variant in BRCA1 or BRCA2. Testing is generally offered when a person's history suggests a higher chance of carrying one: a relative already known to carry a variant, Ashkenazi Jewish ancestry, breast cancer at age 50 or younger in the person or a relative, or a personal or family history of ovarian cancer, male breast cancer, pancreatic cancer, or prostate cancer that has spread or is high risk. Primary care clinicians often use a short family history questionnaire to decide who should be referred. Genetic counseling before and after testing helps people understand what a result could mean for them and their relatives. A positive result means a harmful variant was found. A negative result is most informative when it rules out a variant already known in the family; otherwise it does not erase risk suggested by family history. A third possibility is a variant of uncertain significance (VUS), a gene change without enough evidence to call it harmful or harmless. Most are later reclassified as harmless, and until then care is based on family history rather than the VUS. Some people first learn of a BRCA variant when a tumor is tested to guide cancer treatment. A change found in a tumor may or may not have been inherited, so a separate test of blood or saliva is needed to know. Consumer genetic tests may check only a few variants and can miss harmful ones. Professional groups do not recommend testing children under 18, since no risk-reducing steps are designed for children and BRCA-related cancers in childhood are very unlikely.

Treatment Options

There is no treatment that removes the inherited variant, but there are well-established ways to lower cancer risk or find cancer earlier. Most people combine options over time, and the choices depend on which gene is involved, age, plans for having children and personal priorities. Enhanced breast screening usually means starting earlier than the general population and adding breast MRI to mammograms. MRI finds more cancers but also produces more false alarms that lead to extra tests. For the ovaries, the picture is different: no screening method, including pelvic ultrasound or the CA-125 blood test (a protein that can be raised in ovarian cancer), has been shown to find ovarian cancer early enough to improve survival. That is why surgery plays a central role. Removing the ovaries and fallopian tubes (risk-reducing salpingo-oophorectomy) lowers the risk of ovarian cancer and may lower breast cancer risk. Done before natural menopause, it brings on menopause right away, with effects such as hot flashes and changes in bone health and sexual function, and it ends the ability to become pregnant with one's own eggs. Removing only the fallopian tubes first and the ovaries later is being studied for people not yet ready for that step. Removing both breasts (risk-reducing mastectomy) greatly lowers breast cancer risk; reconstruction is optional, and body image is an important part of the decision. These operations cannot be reversed and cannot remove every at-risk cell, so a small risk remains. Some people consider medicines instead of or before surgery. Tamoxifen, a medicine that blocks estrogen's effects in breast tissue, may lower breast cancer risk for some carriers, particularly BRCA2 carriers and those who have already had breast cancer, although it is not specifically approved for BRCA carriers. Birth control pills are linked to about half the risk of ovarian cancer, a benefit weighed against a possible small increase in breast cancer risk. Men with a BRCA variant, especially BRCA2, are usually advised to discuss breast checks and earlier prostate cancer screening. Pancreatic screening may be offered when a close relative has had pancreatic cancer, although whether it saves lives is still being studied. If cancer does develop, BRCA status helps guide treatment. Cancers with BRCA changes can respond well to platinum chemotherapy and to PARP inhibitors, targeted medicines that stop cancer cells from repairing their DNA, such as olaparib (Lynparza). Some people with breast cancer choose removal of both breasts as part of treatment because of the higher risk of a second breast cancer.

What to Expect

Learning about HBOC usually begins a long-term plan rather than an immediate change in health. Many carriers spend years in a regular routine of yearly breast MRI and mammograms, and planned surgery at a chosen point in life. Decisions about timing, especially about the ovaries, often depend on family plans, and many people revisit them as life changes. Specialized high-risk breast or cancer genetics clinics can coordinate this care. A result can affect the whole family. Close relatives, including brothers, sons and fathers, can be offered testing for the specific variant, and a negative result for a relative tested for the family's known variant means they did not inherit it and cannot pass it on. For people planning a pregnancy, genetic testing of embryos or during pregnancy is possible once the family variant is known. Deciding when and how to tell relatives, managing worry about cancer, and the effects of surgery on body image and menopause are common challenges, and genetic counselors and support groups for carriers can help. Screening and surgery recommendations also change as research advances, so it is worth reviewing the plan every few years.

When to Seek Help

Ask your clinician about genetic counseling if a relative is known to carry a BRCA variant, or if your family includes breast cancer at a young age, ovarian, pancreatic, male breast or advanced prostate cancer, or Ashkenazi Jewish ancestry. If you carry a variant, contact your care team without waiting for your next scheduled scan if you notice a new breast or armpit lump, nipple discharge, skin dimpling or a change in breast shape, or persistent bloating, belly or pelvic pain or pressure, feeling full quickly, or a new urge to urinate often. These symptoms usually have other causes, but they warrant prompt evaluation in someone at high risk.

Questions to Ask Your Doctor

  1. 1.Given my personal and family history, should I see a genetic counselor, and which test makes sense for me?
  2. 2.What do my results mean for my risk, and for my children, parents and siblings?
  3. 3.What screening schedule do you recommend for me, and at what age should it start?
  4. 4.If I consider risk-reducing surgery, when would it make sense, and how would early menopause or reconstruction be managed?
  5. 5.Are there specialized high-risk clinics or support resources you would recommend?

Last reviewed • Oct 2026

Educational content, not medical advice.